Quantcast

Latest Boston Scientific Corporation Stories

2014-07-14 08:27:37

Innovative Technology Strengthens Company's Leading Portfolio of Solutions for Peripheral Vascular Disease MARLBOROUGH, Mass., July 14, 2014 /PRNewswire/ -- Demonstrating its continued leadership in the development of innovative solutions for peripheral vascular disease, Boston Scientific Corporation (NYSE: BSX) has received CE Mark for the Ranger(TM) Paclitaxel-Coated PTA Balloon Catheter. The technology is now in full European market launch. The Ranger Drug-Coated Balloon (DCB)...

2014-07-01 08:29:58

MARLBOROUGH, Mass., July 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results, business highlights and outlook for the second quarter ended June 30, 2014 on Thursday, July 24, 2014 at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, president and chief executive officer, and Dan Brennan, executive vice president and chief financial officer. A live webcast of the conference call will be available via...

2014-06-11 20:22:38

Data Presented at the 18th International Congress of Parkinson's Disease and Movement Disorders Demonstrate Highly Significant Improvement in Motor Function for Patients with Parkinson's Disease NATICK, Mass., June 11, 2014 /PRNewswire/ -- Patients with Parkinson's disease (PD) treated with the Boston Scientific Corporation (NYSE: BSX) Vercise(TM) Deep Brain Stimulation (DBS) System demonstrated a highly significant and consistent improvement in motor scores, according to the latest one-year...

2014-06-10 20:23:03

Data Presented at the International Congress of Parkinson's Disease and Movement Disorders Demonstrate Superior Therapeutic Window for the Treatment of Parkinson's Disease NATICK, Mass., June 10, 2014 /PRNewswire/ -- A new study has demonstrated a therapeutic advantage for a unique and innovative capability of the Boston Scientific (NYSE: BSX) Vercise(TM) Deep Brain Stimulation (DBS) System for the treatment of Parkinson's disease (PD). The CUSTOM-DBS clinical study demonstrated that shorter...

2014-06-05 00:21:14

NATICK, Mass., June 4, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the RESPOND Post Market Registry to assess real world performance of the Lotus(TM) Valve System. The RESPOND Registry will collect data on clinical outcomes and device performance in 1,000 patients implanted at 50 centers around the world. Three patients enrolled in the RESPOND Registry thus far have been successfully implanted with the Lotus Valve System. Dr. Nicolas Van Mieghem and...

2014-06-03 12:36:31

NATICK, Mass., June 3, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Wells Fargo 2014 Healthcare Conference on June 17 in Boston, MA. Dan Brennan, executive vice president and chief financial officer, and Susan Lisa, vice president, Investor Relations, will participate in a 30-minute question and answer session regarding the company beginning at approximately 8:50 a.m. ET. A live webcast of the question and answer session will be...

2014-06-03 08:32:11

NATICK, Mass., June 3, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs 35th Annual Global Healthcare Conference on June 10 in Rancho Palos Verdes, CA. David Pierce, senior vice president and president, Endoscopy, and Susan Lisa, vice president, Investor Relations, will participate in a 35-minute question and answer session regarding the company beginning at approximately 9:20 a.m. PT. A live webcast of the question and...

2014-05-21 08:29:14

EVOLVE Study Data Presented Today at EuroPCR 2014 Also Demonstrate Excellent Safety Profile NATICK, Mass., May 21, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reported positive three-year follow-up data for the EVOLVE clinical trial, comparing the safety and performance of the SYNERGY(TM) Everolimus-Eluting Bioabsorbable Polymer Platinum Chromium (PtCr) Coronary Stent System to the PROMUS Element(TM) Stent System. The data were presented today at EuroPCR 2014 by...

2014-05-15 08:31:33

Acquisition Expected to Strengthen Peripheral Interventions Business and Accelerate Growth in Peripheral Atherectomy and Thrombectomy Categories NATICK, Mass., May 15, 2014 /PRNewswire/ -- In a move to expand significantly its portfolio of leading solutions for peripheral interventions, Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire the Interventional Division of Bayer AG for $415 million in cash, including fees for transitional services....

2014-05-15 04:22:35

PARIS, May 15, 2014 /PRNewswire/ -- Boston Scientific Reinforces Its Commitment to Global Education and Innovation Boston Scientific Corporation (NYSE:BSX) celebrated the opening of a new facility dedicated to endoscopy training within its Institute for Advancing Science in Paris. The ceremony included major representatives of the endoscopy medical community in Europe. Endoscopy professional training and education is...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related